Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Allelica S R L is currently prosecuting 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This case is assigned to LUO, JAMMY NMN, who serves as the busiest examiner for the company. The entire pending workload is currently under this individual's review, which suggests that the company's intellectual property strategy is focused on a specific technical path.
The administrative profile shows 1 distinct examiner and 1 distinct art unit involved in the process. The 1 distinct art unit indicates that the technical claims are being evaluated within a specific division of the patent office. For a practitioner, this means the prosecution strategy is centered on the requirements of this division rather than multiple units. The 1 distinct examiner represents the total number of officials currently reviewing the company's applications.
With LUO, JAMMY NMN handling 1 busiest examiner pending office action, the company's success is tied to the discretion of this individual. Practitioners should monitor the 1 pending office action to understand the specific hurdles being raised in the Biotechnology & Pharmaceuticals sector. The results of this prosecution will define the company's immediate path within the patent office's administrative framework.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LUO, JAMMY NMN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252792 | METHOD FOR PERFORMING IMPUTATION AND/OR ENRICHMENT OF GENETIC DATA IN AN OPTIMIZED MANNER | LUO, JAMMY NMN | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18252792 | METHOD FOR PERFORMING IMPUTATION AND/OR ENRICHMENT OF GENETIC DATA IN AN OPTIMIZED MANNER | LUO, JAMMY NMN | 1686 | §101§103§112 | Non-Final OA | — | Pending | May 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAllelica S R L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jammy Nmn Luo has the most, with 1 of Allelica S R L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
